EpCAM and Wnt signaling could form an interaction cycle in colon cancer in cancer stem cell, immune modulation, etc. The novelty in our research is to report the synergetic activity of hsBCL9CT-24 with EpCAM-CAR-T, which was not reported in other combinational therapies of CAR-T before. Here, EPCAM is linked to cancer.